Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL5172662 | 1.00 | TDP1 (0.39) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL28929329 | 1.00 | TDP1 (0.39) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL26672381 | 1.00 | TDP1 (0.39) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL41276 | 1.00 | TDP1 (0.39) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL11683975 | 0.98 | TDP1 (0.38) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL28421563 | 0.98 | TDP1 (0.38) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL25256637 | 0.96 | TDP1 (0.41) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL5029016 | 0.96 | TDP1 (0.41) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL21670809 | 0.96 | TDP1 (0.41) | TDP1TSHRTGFBR1 | |
| Methacrylic Acid SCHEMBL672402 | 0.96 | TDP1 (0.41) | TDP1TSHRTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| US-12036312-B2 | Non-aqueous topical compositions comprising a halogenated salicylanilide | UNION therapeutics A/S (DK) | 2024-07-16 | — | — | US | claimed |
| CN-112313577-B | Radiation curable composition for additive manufacturing | 斯特拉塔西斯公司 | 2024-07-09 | — | — | CN | claimed |
| CN-117567979-A | High-temperature-resistant reversible self-repairing UV and moisture dual-curing three-proofing adhesive | 信泰永合(烟台)新材料有限公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| US-20230407132-A1 | (METH)ACRYLATE-FUNCTIONAL RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-12-21 | — | — | US | claimed |
| EP-4237175-A1 | (METH)ACRYLATE-FUNCTIONAL RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | Covestro (Netherlands) B.V. (NL) | 2023-09-06 | — | — | EP | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| US-11485818-B2 | Radiation curable compositions for additive fabrication | COVESTRO (NETHERLANDS) B.V. (NL) | 2022-11-01 | — | — | US | claimed |
| US-7906564-B2 | Self etch all purpose dental cement composition, method of manufacture, and method of use thereof | PENTRON CLINICAL TECHNOLOGIES, LLC (US) | 2011-03-15 | — | — | US | claimed |
| CN-101720239-A | Implant device release agent and method of use thereof | ENDO PHARMACEUTICALS SOLUTIONS | 2010-06-02 | — | — | CN | claimed |
| EP-2139533-A2 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | Endo Pharmaceuticals Solutions Inc. (US) | 2010-01-06 | — | — | EP | claimed |
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | INDEVUS PHARMACEUTICALS, INC. | 2008-12-18 | — | — | US | claimed |
| WO-2008134475-A2 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | ENDO PHARMACEUTICALS SOLUTIONS INC., 33 (US) | 2008-11-06 | — | — | WO | claimed |
| EP-1986588-A2 | SELF ETCH ALL PURPOSE DENTAL COMPOSITION | Pentron Clinical Technologies, LLC (US) | 2008-11-05 | — | — | EP | claimed |
| US-20080242761-A1 | One part acrylated monomer with aromatic carboxylic anhydride functionality, multifunctional acrylate resin, diluent monomer and curing system; one step restorative dentistry; self and light curable | JIA WEITAO | 2008-10-02 | — | — | US | claimed |
| WO-2007100569-A2 | SELF ETCH ALL PURPOSE DENTAL COMPOSITION | PENTRON CLINICAL TECHNOLOGIES LLC (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070197683-A1 | SELF ETCH ALL PURPOSE DENTAL COMPOSITIONS, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF | PENTRON CLINICAL TECHNOLOGIES, INC (US) | 2007-08-23 | — | — | US | claimed |
| US-20070197682-A1 | Self etch all purpose dental cement composition, method of manufacture, and method of use thereof | PENTRON CORPORATION | 2007-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197682-A1 | Self etch all purpose dental cement composition, method of manufacture, and method of use thereof | FHIT, COPE, ASH2L | TDP1 2404/4885TSHR 4848/4885TGFBR1 4506/4885 |
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | PTGES, VDR, HPGDS | TDP1 2445/4885TSHR 476/4885TGFBR1 830/4885 |
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | TDP1 2457/4885TSHR 4571/4885TGFBR1 1771/4885 |
| US-12036312-B2 | Non-aqueous topical compositions comprising a halogenated salicylanilide | CUTA, PTPN21, ABL2 | TDP1 1830/4885TSHR 3500/4885TGFBR1 4142/4885 |
| US-20070197683-A1 | SELF ETCH ALL PURPOSE DENTAL COMPOSITIONS, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF | CAD, FHIT, ACR | TDP1 1797/4885TSHR 4432/4885TGFBR1 4533/4885 |
| US-20080242761-A1 | One part acrylated monomer with aromatic carboxylic anhydride functionality, multifunctional acrylate resin, diluent monomer and curing system; one step restorative dentistry; self and light curable | CAD, TAS2R42, ACR | TDP1 967/4885TSHR 3760/4885TGFBR1 1059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.